Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Enrofloxacin
Global Vet Health S.L.
QJ01MA90
Enrofloxacin
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Pigs
Antimicrobial
Authorized
2012-12-19
Revised: March 2023 AN: 00831/2022 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quinoflox 100 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Enrofloxacin 100.0 mg EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUCt Benzyl alcohol 0.02 ml Lactic acid Disodium edetate Water for injections Clear yellow solution 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle and pigs. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES CATTLE Treatment of infections of the respiratory tract caused by _ Mannheimia haemolytica, _ _Mycoplasma _spp and_ Pasteurella multocida_. Treatment of infections of the alimentary tract caused by _Escherichia coli_. Treatment of septicaemia caused by _Escherichia coli_. Treatment of acute mycoplasma-associated arthritis due to _ Mycoplasma bovis _ in cattle less than 2 years old. PIGS Treatment of infections of the respiratory tract caused by _Actinobacillus _ _pleuropneumoniae, Mycoplasma _spp. and_Pasteurella multocida . _ Revised: March 2023 AN: 00831/2022 Page 2 of 8 Treatment of infections of the urinary tract caused by _Escherichia coli. _ Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by _Escherichia coli _and _Klebsiella _spp. Treatment of infections of the alimentary tract caused by _Escherichia coli_. Treatment of septicaemia caused by _Escherichia coli_. 3.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in growing horses because of possible deleterious damage on articular cartilage. Do not use in animals with central nervous system-associated seizure disorders. 3.4 SPECIAL WARNINGS None. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: Degenerative changes of articular cartilage were obs Read the complete document